Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02428894 · ClinicalTrials.gov registry record
Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation
A clinical trial of Ventricular Dysfunction, Left, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02428894 is a study of Ventricular Dysfunction, Left that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02428894, a study of Ventricular Dysfunction, Left, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize changes in the plasma proteome over time following left ventricular assist device (LVAD) implantation.
Conditions Studied
Interventions
- DEVICE LVAD
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02428894
The ClinicalTrials.gov registry entry for NCT02428894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Dysfunction, Left appearing as the primary indexed condition, and to 1 intervention - of which LVAD is the first listed.
NCT02428894 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT02428894 about?
NCT02428894 is a clinical study titled "Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation". The purpose of this study is to characterize changes in the plasma proteome over time following left ventricular assist device (LVAD) implantation.
What is the current status of trial NCT02428894?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-10. Estimated completion is 2017-01.
What conditions does trial NCT02428894 study?
This clinical trial studies the following conditions: Ventricular Dysfunction, Left.
What interventions are being tested in trial NCT02428894?
The interventions under investigation include: LVAD (DEVICE).
Who is sponsoring clinical trial NCT02428894?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02428894 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Dysfunction, Left
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.